Ah75217700072870354 RLS

PROCESSED AT :
Thyrocare,Sohrabh Hall,
112, A Wing, 1st Floor,
Sangamwadi, Pune – 411 001
NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

REF. BY A WING FLAT NO 602 LUNKAD GREENLAND-2
: SELF
411014 INDIA
TEST ASKED : Prime Preventive Health Checkup + Urine
PATIENTID : VS18866723
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 5.3 %
Reference Range :
Reference Range: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C. using Biorad Variant II Turbo
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 105 mg/dl
Reference Range :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 17 Jul 2022 10:18
Sample Received on (SRT) : 17 Jul 2022 14:31

Report Released on (RRT) : 17 Jul 2022 17:00
Sample Type : EDTA
Labcode : 1707075278/DS650 Dr Keerthi K MD(Path) Dr Gajanan A MD(Path)
Barcode : Y4640352
Page : 1 of 13
PROCESSED AT :

REF. BY : SELF A WING FLAT NO 602 LUNKAD GREENLAND-2
411014 INDIA
TEST NAME VALUE UNITS REFERENCE RANGE
TOTAL LEUCOCYTES COUNT (WBC) 6.28 X 10³ / µL 4.0-10.0
NEUTROPHILS 57.3 % 40-80
LYMPHOCYTE PERCENTAGE 36.5 % 20-40
MONOCYTES 2.4 % 0-10
EOSINOPHILS 3.3 % 0.0-6.0
BASOPHILS 0.2 % <2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.3 % 0-0.5
NEUTROPHILS - ABSOLUTE COUNT 3.6 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT 2.29 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT 0.15 X 10³ / µL 0.2-1
BASOPHILS - ABSOLUTE COUNT 0.01 X 10³ / µL 0-0.1
EOSINOPHILS - ABSOLUTE COUNT 0.21 X 10³ / µL 0-0.5
IMMATURE GRANULOCYTES(IG) 0.02 X 10³ / µL 0-0.3
TOTAL RBC 4.86 X 10^6/µL 4.5-5.5
NUCLEATED RED BLOOD CELLS Nil X 10³ / µL <0.01
NUCLEATED RED BLOOD CELLS % Nil % <0.01
HEMOGLOBIN 16.1 g/dL 13-17
HEMATOCRIT(PCV) 45.6 % 40-50
MEAN CORPUSCULAR VOLUME(MCV) 93.8 fL 83-101
MEAN CORPUSCULAR HEMOGLOBIN(MCH) 33.1 pq 27-32
MEAN CORP.HEMO.CONC(MCHC) 35.3 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 52.6 fL 39-46
RED CELL DISTRIBUTION WIDTH (RDW-CV) 15.3 % 11.6-14
PLATELET DISTRIBUTION WIDTH(PDW) 17.3 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) 12.8 fL 6.5-12
PLATELET COUNT 261 X 10³ / µL 150-400
PLATELET TO LARGE CELL RATIO(PLCR) 46.4 % 19.7-42.4
PLATELETCRIT(PCT) 0.33 % 0.19-0.39
Remarks : Alert!!! RBCs:Mild anisopoikilocytosis. Predominantly normocytic normochromic with ovalocytes. Platelets:Appear
adequate in smear.
Please Correlate with clinical conditions.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow
Cytometry Method (using a semiconductor laser), and SLS- hemoglobin method)

Sample Type : EDTA
Barcode : Y4640352 Page : 2 of 13
PROCESSED AT :

: SELF
411014 INDIA
APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 111 mg/dL

Reference Range :
Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 129 mg/dL
Reference Range :
Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APO B / APO A1 RATIO (APO B/A1) CALCULATED 1.2 Ratio
Reference Range :
Male : 0.40 - 1.26
Female : 0.38 - 1.14
Method : DERIVED FROM SERUM APO A1 AND APO B VALUES

Sample Type : SERUM
Barcode : Z3668615
Page : 3 of 13
PROCESSED AT :

411014 INDIA
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 3.19 mg/L
Reference Range :-
Adult : <=3.0 mg/L
Interpretation:
High sensitivity C-reactive protein, when used in conjunction with other clinical laboratory evaluation of acute coronary syndromes,
may be useful as an independent marker of prognosis for recurrent events, in patients with stable coronary disease or acute coronary
syndromes. hsCRP levels should not be substituted for assessment of traditional cardiovascular risk factors. Patients with persistently
unexplained, marked evaluation of hsCRP after repeated testing should be evaluated for non - cardiovascular etiologies
Clinical significance:
hsCRP measurements may be used as an independent risk marker for the identification of individuals at risk for future cardiovascular
disease. Elevated CRP values may be indicative of prognosis of individuals with acute coronary syndromes, and may be useful in the
management of such individuals.
Specifications: Precision: Within run %CV has been recorded <=5%.
References:
1. Chenillot O, Henny J, Steinmez J, et al. High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab
Med 2000;38:1003-11.
2. Hind CRH, Pepys MB. The role of serum C-reactive protein measurements in clinical practice. Int Med 1984;5:112-51.
Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Type : SERUM
Dr Keerthi K MD(Path) Dr Gajanan A MD(Path)
Labcode : 1707073978/DS650
Barcode : Z3668615 Page : 4 of 13
PROCESSED AT :

411014 INDIA
LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 9.7 mg/dl
Reference Range :-
Adults : < 30.0 mg/dl
Interpretation:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for diagnostic
purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and other findings.
Specifications:
Precision: Intra Assay (%CV): 3.4 %, Inter Assay (%CV): 2.0 %; Sensitivity: 0.002 gm/l
External Quality Control Program Participation:
College of American Pathologists: General Chemistry and TDM; CAP Number: 7193855-01
Kit Validation References:
Koschinsky ML, Marcovina SM. Lipoprotein A: Structural Implication for Pathophysiology. Int J Clin Lab Res, 1997; 27: 14-23.
Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Type : SERUM
Labcode : 1707073978/DS650
PROCESSED AT :

: SELF
411014 INDIA
IRON PHOTOMETRY 97.3 µg/dl

Reference Range :
Male : 65 - 175
Female : 50 - 170
Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION
TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 297 µg/dl
Reference Range :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl
Method : SPECTROPHOTOMETRIC ASSAY
% TRANSFERRIN SATURATION CALCULATED 32.76 %
Reference Range :
13 - 45
Method : DERIVED FROM IRON AND TIBC VALUES

Sample Type : SERUM
Barcode : Z3668615
Page : 6 of 13
PROCESSED AT :

REF. BY A WING FLAT NO 602 LUNKAD GREENLAND-2 411014
: SELF
INDIA
TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE
TOTAL CHOLESTEROL PHOTOMETRY 226 mg/dl < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 33 mg/dl 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 154 mg/dl < 100
TRIGLYCERIDES PHOTOMETRY 227 mg/dl < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 6.9 Ratio 3-5
LDL / HDL RATIO CALCULATED 4.7 Ratio 1.5-3.5
VLDL CHOLESTEROL CALCULATED 45.4 mg/dl 5 - 40
NON-HDL CHOLESTEROL CALCULATED 193.28 mg/dl < 160
Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES
VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES
NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500

VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Type : SERUM
PROCESSED AT :

: SELF
INDIA
ALKALINE PHOSPHATASE PHOTOMETRY 115 U/L 45 - 129
BILIRUBIN - TOTAL PHOTOMETRY 1.98 mg/dl 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.5 mg/dl < 0.3
BILIRUBIN (INDIRECT) CALCULATED 1.48 mg/dl 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 50 U/l < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 66 U/l < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 161.59 U/l < 45
PROTEIN - TOTAL PHOTOMETRY 8.15 gm/dl 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.52 gm/dl 3.2-4.8
SERUM ALB/GLOBULIN RATIO CALCULATED 1.25 Ratio 0.9 - 2
SERUM GLOBULIN CALCULATED 3.63 gm/dL 2.50-3.40
Method :
ALKP - MODIFIED IFCC METHOD
BILT - VANADATE OXIDATION
BILD - VANADATE OXIDATION
BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES
GGT - MODIFIED IFCC METHOD
SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION
PROT - BIURET METHOD
SALB - ALBUMIN BCG¹METHOD (COLORIMETRIC ASSAY ENDPOINT)
A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES

Sample Type : SERUM
PROCESSED AT :

: SELF
INDIA
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 10.6 mg/dl 7 - 25
CREATININE - SERUM PHOTOMETRY 0.74 mg/dl 0.6-1.1
BUN / SR.CREATININE RATIO CALCULATED 14.32 Ratio 9:1-23:1
CALCIUM PHOTOMETRY 9.7 mg/dl 8.8-10.6
URIC ACID PHOTOMETRY 8 mg/dl 4.2 - 7.3
Method :
BUN - KINETIC UV ASSAY.
SCRE - CREATININE ENZYMATIC METHOD
B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES
CALC - ARSENAZO III METHOD, END POINT.
URIC - URICASE / PEROXIDASE METHOD

Sample Type : SERUM
PROCESSED AT :

A WING FLAT NO 602 LUNKAD GREENLAND-2 411014
REF. BY : SELF
INDIA
TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE
TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 98 ng/dl 60-200

TOTAL THYROXINE (T4) C.L.I.A 5.9 µg/dl 4.5-12
THYROID STIMULATING HORMONE (TSH) C.L.I.A 5.01 µIU/ml 0.3-5.5
Comments : SUGGESTING THYRONORMALCY

Method :
T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY
TSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
PROCESSED AT :

411014 INDIA
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 124 mL/min/1.73 m2
Reference Range :-
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and moderate
kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely estimate
glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum
creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice,
instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the
doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining.
Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and
management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate.
Ann Intern Med. 2009;150(9):604-12.
Method:- CKD-EPI Creatinine Equation

Sample Type : SERUM
Labcode : 1707073978/DS650
PROCESSED AT :

A WING FLAT NO 602 LUNKAD GREENLAND-2
REF. BY : SELF
411014 INDIA
TEST NAME OBSERVATION UNITS REFERENCE RANGE
COMPLETE URINOGRAM
VOLUME 3 mL -
COLOUR Straw - Pale Yellow
APPEARANCE CLEAR - Clear
SPECIFIC GRAVITY 1.02 - 1.003-1.030
PH 5 - 5-8
URINARY PROTEIN ABSENT mg/dl Absent
URINARY GLUCOSE ABSENT mg/dl Absent
URINE KETONE ABSENT mg/dl Absent
URINARY BILIRUBIN ABSENT mg/dl Absent
UROBILINOGEN < 0.2 mg/dl <=0.2
BILE SALT ABSENT - Absent
BILE PIGMENT ABSENT - Absent
URINE BLOOD ABSENT Cells/ul* Absent
NITRITE ABSENT - Absent
MICROALBUMIN 10 mg/l < 20
MUCUS ABSENT - Absent
RED BLOOD CELLS ABSENT Cells/ul* Absent
URINARY LEUCOCYTES (PUS CELLS) ABSENT Cells/ul* Absent
EPITHELIAL CELLS 1-2 - 0-4
CASTS ABSENT - Absent
CRYSTALS ABSENT - Absent
BACTERIA ABSENT - Absent
YEAST ABSENT - Absent
PARASITE ABSENT - Absent
* To Obtain Counts in Cells / HPF Divide the Cells / ul by 5
Method : Fully Automated DIRUI H-100 Urinalysis Dipstick Method, Microscopy
~~ End of report ~~

Sample Type : URINE
Labcode : 1707073844/DS650
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the
same patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage
that may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
Page : 13 of 13

Ah75217700072870354 RLS

Uploaded by

Copyright:

Available Formats

Ah75217700072870354 RLS

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Ah75217700072870354 RLS

Uploaded by

Copyright:

Available Formats

PROCESSED AT :

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

Reference Range: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

Sample Collected on (SCT) : 17 Jul 2022 10:18

Sample Received on (SRT) : 17 Jul 2022 14:31

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

Sample Collected on (SCT) : 17 Jul 2022 10:18

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 111 mg/dL

Sample Collected on (SCT) : 17 Jul 2022 10:18

Sample Received on (SRT) : 17 Jul 2022 14:19

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

Adult : <=3.0 mg/L

Specifications: Precision: Within run %CV has been recorded <=5%.

Sample Collected on (SCT) : 17 Jul 2022 10:18

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

Adults : < 30.0 mg/dl

External Quality Control Program Participation:

Kit Validation References:

Sample Collected on (SCT) : 17 Jul 2022 10:18

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

IRON PHOTOMETRY 97.3 µg/dl

Sample Collected on (SCT) : 17 Jul 2022 10:18

Sample Received on (SRT) : 17 Jul 2022 14:19

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499

HIGH 160-189 VERY HIGH >500

Sample Collected on (SCT) : 17 Jul 2022 10:18

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

Sample Collected on (SCT) : 17 Jul 2022 10:18

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

Sample Collected on (SCT) : 17 Jul 2022 10:18

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE

TOTAL TRIIODOTHYRONINE (T3) C.L.I.A 98 ng/dl 60-200

Comments : SUGGESTING THYRONORMALCY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 17 Jul 2022 10:18

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

Sample Collected on (SCT) : 17 Jul 2022 10:18

NAME : VISHAL SINGH(30Y/M) HOME COLLECTION :

Sample Collected on (SCT) : 17 Jul 2022 10:18

You might also like